<DOC>
	<DOCNO>NCT01664689</DOCNO>
	<brief_summary>Ophthalmic Viscosurgical Devices ( OVDs ) play crucial role phacoemulsification , provide endothelial protection , maintain space , well facilitate surgical maneuver , include IOL implantation . Equally important ease use , good visualisation easy removal OVD eye . Currently , 3 popularly use OVDs single injection suffice surgery : Healon 5 , DiscoVisc , Celoftal ( 2 % hydroxypropylmethylcellulose ) . Whereas , study show efficacy clinical scenario , randomize trial compare intraoperative performance postoperative outcome . The aim study compare intraoperative performance postoperative outcome follow microcoaxial phacoemulsification use one three OVDs</brief_summary>
	<brief_title>Intraoperative Postoperative Outcomes Three Ophthalmic Viscosurgical Devices During Phacoemulsification</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Age relate , uncomplicated senile cataract presence glaucoma , shallow anterior chamber ( ACD &lt; 2.1mm ) , pupillary dilatation &lt; 6mm , extremely dense cataract , posterior polar cataract , subluxate cataract , white mature cataract , diabetic retinopathy , high myopia ( define AL &gt; 25mm ) , uveitis , previous ocular trauma/surgery .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>